MedPath

Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)

Not Applicable
Completed
Conditions
Opioid Cessation
Interventions
Behavioral: Motivational Interviewing and Physician Guided Opioid Weaning
Registration Number
NCT02070003
Lead Sponsor
Stanford University
Brief Summary

The investigators aim to characterize the relationship between changes in emotional distress, opioid use, and pain throughout surgery and recovery. Additionally, the investigators aim to compare the effectiveness of post-surgical motivational interviewing and physician-guided opioid weaning vs. usual care on reducing persistent opioid use. Overall, the proposed research will advance knowledge regarding the role of psychological factors contributing to persistent opioid use after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • Age 18+
  • Undergoing a scheduled surgery
  • English speaking
  • Ability and willingness to complete questionnaires and assessments.
Read More
Exclusion Criteria
  • Any conditions causing inability to complete baseline, telephone and internet assessments (e.g. education, cognitive ability, mental status, medical status)at the discretion of the investigator.
  • Known Pregnancy
  • Elevated Suicidality as assessed by an answer of 2 or greater on question 9 of the Beck Depression Inventory assessing suicidal thoughts.
  • Coexisting Chronic Pain Disorder of moderate severity in area other than surgical target
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motivational Interviewing and Physician Guided Opioid WeaningMotivational Interviewing and Physician Guided Opioid WeaningPatients will go through motivational interviewing with the study physician via phone once a week for 7 weeks, and once a month up to a year as applicable, until patient completes the protocol.
Primary Outcome Measures
NameTimeMethod
Trial Feasibility - The proportion of people consented who complete the study in the group to which they were randomizedDuration of the study - up to 2 years per participant

Factors that contribute to non-completion of the study, measured at baseline for each patient, will be analyzed.

Secondary Outcome Measures
NameTimeMethod
Efficacy - time to opioid cessationDuration of the trial - Up to 2 years per participant

Time to opioid cessation between the two groups will be analyzed using survival analysis

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath